PBEvsSPTM
Invesco Dynamic Biotechnology & Genome ETF against SPDR Portfolio S&P 1500 Composite Stock Market ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| PBE | SPTM | |
|---|---|---|
| Expense ratio | 0.58% | 0.030% |
| Assets | $424M | $14B |
| Net flow, 1 month | −$50M | −$41M |
| Net flow, 1 year | +$114M | +$815M |
| Return, YTD | +15.8% | +11.9% |
| Return, 1 year | +32.8% | +14.0% |
| Avg daily volume | 18K | 452K |
| Holdings | 31 | 1510 |
| Listed | Jun 23, 2005 | Oct 4, 2000 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS